Brief: Imugene Says Co And Neoimmunetech To Improve Cancer Treatments
12/12/2023 01:39
Dec 12 (Reuters) - Imugene Ltd IMU.AX :
* IMUGENE AND NEOIMMUNETECH TO IMPROVE CANCER TREATMENTS
* COLLABORATION WILL EVALUATE ABILITY OF NEOIMMUNETECH'S
IMMUNE
CELL AMPLIFIER NT-I7
Source text for Eikon: ID:nASX2bdWLV
Further company coverage: IMU.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imugene
See all newsAustralia's Imugene rises on fresh responses in blood cancer drug trial
Brief: Imugene Ltd Says Leslie Chong Resigns As CEO
Australia's Imugene loses most in over 8-years on discounted placement
Brief: Imugene To Raise A$11.12 Million Via Placement At A$0.095 Per Share
Brief: Imugene Requests Trading Halt Pending Proposed Capital Raising Announcement